PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically proven coronary artery disease.

PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically proven coronary artery disease.

MARTINELLI, Nicola;GIRELLI, Domenico;TRABETTI, Elisabetta;MALERBA, Giovanni;CONSOLI, Letizia;MICAGLIO, Roberta;FRISO, Simonetta;PIZZOLO, Francesca;PIGNATTI, Pierfranco;CORROCHER, Roberto;OLIVIERI, Oliviero
2010

Abstract

PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically proven coronary artery disease.
paraoxonase; PON2 genotype; cardiovascular mortality
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/433149
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact